Results from a phase I proof-of-mechanism study with a vasopressin 1A receptor antagonist in autism spectrum disorder

被引:0
|
作者
Rubido, M. Del Valle [1 ]
Umbricht, D. [1 ]
Shic, F. [2 ]
McCracken, J. T. [3 ]
Scahill, L. [4 ]
Khwaja, O. [1 ]
Squassante, L. [5 ]
Boak, L. [1 ]
Bolognani, F. [1 ]
Fontoura, P. [6 ]
Wall, C. [2 ]
Jou, R. [2 ]
Loomis, R. [2 ]
Lyons, M. [2 ]
Gavaletz, A. [2 ]
Cowen, J. [3 ]
Apelian, T. [3 ]
Jeste, S. [3 ]
Ferretti, C. [7 ]
Taylor, B. [7 ]
Berlin, G. [7 ]
Noone, R. [7 ]
Antar, L. [7 ]
Hollander, E. [7 ]
机构
[1] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Translat Med NORD, Basel, Switzerland
[2] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA
[3] Univ Calif Los Angeles, Semel Inst, CAN Clin, Psychiat & Biobehav Sci, Los Angeles, CA USA
[4] Emory Univ, Marcus Autism Ctr, Atlanta, GA 30322 USA
[5] F Hoffmann La Roche Ltd, Prod Dev Biometr, Basel, Switzerland
[6] F Hoffmann La Roche Ltd, Prod Dev Neurosci, Basel, Switzerland
[7] Albert Einstein Coll Med, Psychiat, New York, NY USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P.7.d.011
引用
收藏
页码:S646 / S647
页数:2
相关论文
共 50 条
  • [21] Predictors of placebo response in three large clinical trials of the V1a receptor antagonist balovaptan in autism spectrum disorder
    Russell Tobe
    Yajing Zhu
    Teresa Gleissl
    Simona Rossomanno
    Jeremy Veenstra-VanderWeele
    Janice Smith
    Eric Hollander
    Neuropsychopharmacology, 2023, 48 : 1201 - 1216
  • [22] Predictors of placebo response in three large clinical trials of the V1a receptor antagonist balovaptan in autism spectrum disorder
    Tobe, Russell
    Zhu, Yajing
    Gleissl, Teresa
    Rossomanno, Simona
    Veenstra-VanderWeele, Jeremy
    Smith, Janice
    Hollander, Eric
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 (08) : 1201 - 1216
  • [23] The Janssen Autism Knowledge Engine (JAKE): Results From a Large, Prospective Observational Biosensor Study in Autism Spectrum Disorder
    Pandina, Gahan
    Nikolay, Manyakov
    Bangerter, Abigail
    Lewin, David
    Jagannatha, Shyla
    Boice, Matthew
    Skalkin, Andrew
    Ness, Seth
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S349 - S349
  • [24] Association between single nucleotide polymorphisms in oxytocin and vasopressin receptor genes and symptom severity of autism spectrum disorder-preliminary study
    Wilczynski, K.
    Cichon, L.
    Augusciak-Duma, A.
    Sieron, A.
    Janas-Kozik, M.
    EUROPEAN PSYCHIATRY, 2021, 64 : S83 - S84
  • [25] Association between the arginine vasopressin 1a receptor (AVPR1a) gene and autism in a family-based study: mediation by socialization skills
    N Yirmiya
    C Rosenberg
    S Levi
    S Salomon
    C Shulman
    L Nemanov
    C Dina
    R P Ebstein
    Molecular Psychiatry, 2006, 11 : 488 - 494
  • [26] Association between the arginine vasopressin 1a receptor (AVPR1a) gene and autism in a family-based study:: mediation by socialization skills
    Yirmiya, N
    Rosenberg, C
    Levi, S
    Salomon, S
    Shulman, C
    Nemanov, L
    Dina, C
    Ebstein, RP
    MOLECULAR PSYCHIATRY, 2006, 11 (05) : 488 - 494
  • [27] Efficacy and safety of memantine in children with autism spectrum disorder: Results from three phase 2 multicenter studies
    Hardan, Antonio Y.
    Hendren, Robert L.
    Aman, Michael G.
    Robb, Adelaide
    Melmed, Raun D.
    Andersen, Kristen A.
    Luchini, Rachel
    Rahman, Rezwanur
    Ali, Sanjida
    Jia, X. Daniel
    Mallick, Madhuja
    Lateiner, Jordan E.
    Palmer, Robert H.
    Graham, Stephen M.
    AUTISM, 2019, 23 (08) : 2096 - 2111
  • [28] Design and methodology for a proof of mechanism study of individualized neuronavigated continuous Theta burst stimulation for auditory processing in adolescents with autism spectrum disorder
    Oberman, Lindsay M.
    Francis, Sunday M.
    Beynel, Lysianne
    Hynd, Megan
    Jaime, Miguel
    Robins, Pei L.
    Deng, Zhi-De
    Stout, Jeff
    van der Veen, Jan Willem
    Lisanby, Sarah H.
    FRONTIERS IN PSYCHIATRY, 2024, 15
  • [29] Molecular genetic studies of the arginine vasopressin 1a receptor (AVPR1a) and the oxytocin receptor (OXTR) in human behaviour: from autism to altruism with some notes in between
    Israel, Salomon
    Lerer, Elad
    Shalev, Idan
    Uzefovsky, Florina
    Reibold, Mathias
    Bachner-Melman, Rachel
    Granot, Roni
    Bornstein, Gary
    Knafo, Ariel
    Yirmiya, Nurit
    Ebstein, Richard P.
    ADVANCES IN VASOPRESSIN AND OXYTOCIN: FROM GENES TO BEHAVIOUR TO DISEASE, 2008, 170 : 435 - 449
  • [30] Children With Autism Spectrum Disorder and Screen Time: Results From a Large, Nationally Representative US Study
    Montes, Guillermo
    ACADEMIC PEDIATRICS, 2016, 16 (02) : 122 - 128